|
|
Genome-based Drug Discovery Market Research
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Genome-based Drug Discovery Market, including, but not limited to latest business trend on: Pharmacogenomics; Lead Optimization; Bioinformatics; ADMET; Genomics; Proteomics; Transcriptomics; Metabonomics; Toxicogenomics.
We offer market research, industry forecasts, and business analysis in the Genome-based Drug Discovery Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
Reports
| Advances in Metabolomics |
|
| Published : 2008/03 |
| This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform. ... |
| Bigpharma Partnering Agreements |
|
| Published : 2008/03 |
| The Bigpharma Partnering Agreements provides comprehensive and unprecedented access to the partnering agreements entered into by the worlds leading fifty biopharma companies. ... |
| Merger and Acquisition Agreements in Biopharma |
|
| Published : 2008/02 |
| The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies.
The report provides a detail ... |
| ADME /TOX TECHNOLOGIES - A MARKET INSIGHT REPORT |
|
| Published : 2008/01 |
| This market insight report on ADME/Tox Technologies covers both products and services used in the ADME/TOX industry. Predictive technologies analyzed include In vivo, In vitro, and In silico. ... |
| Antibiotics and Drug Resistance 2008 |
|
| Published : 2008/01 |
| This report reviews new drug innovation and strategy to combat antibiotic resistance mechanisms. This embraces current research-stage activities, patents published in the last five years, the entire pharmaceutical development pipeline and today' s existin ... |
| Drug Discovery Technologies |
|
| Published : 2007/11 |
| This study examines trends in drug discovery. Drug discovery is an enormous field, and this report focuses on a selection of the major workhorse technologies, including liquid chromatography and mass spectrometry, as well as on newer approaches, such as s ... |
| RNA Interference Markets |
|
| Published : 2007/01 |
| The purpose of this TriMark Publications report is to review the market for RNAi testing equipment and supplies. ... |
| Stem Cell Markets |
|
| Published : 2007/01 |
| The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. ... |
| Comparative Genomic Hybridization: Current State and Future Directions |
|
| Published : 2006/09 |
| Comparative Genomic Hybridization: Current State and Future Directions profiles the major vendors and their CGH product offerings. The report concludes with in-depth interviews with experts in industry and academia, providing authoritative insight into th ... |
| Big Pharma Embraces Pharmacogenomics - But Are We There Yet? |
|
| Published : 2006/08 |
| Pharmacogenomics will revolutionize the drug industry by linking the right drug to the right patient. Several companies and regulatory agencies are leading the charge to implement this approach of developing targeted medicines. ... |
| U.S. RNAi Markets |
|
| Published : 2006/05 |
| The U.S. RNAi markets are rapidly evolving as a growing number of scientists transition their research focus from low-throughput to medium- and high-throughput in one dimension, and from in vitro to in vivo in a second dimension. ... |
| Microarray Markets |
|
| Published : 2006/03 |
| The purpose of this TriMark Publications report is to describe the specific segment of the microarray market aimed at analysis of proteins and DNA. ... |
| GENOMICS WORLD MARKETS |
|
| Published : 2005/09 |
| Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. ... |
| Pharmacodiagnostics: Technologies, Competition, & Market Models |
|
| Published : 2005/07 |
| Pharmacodiagnostics: Technologies, Competition, and Market Models examines the reasons why the business environment of pharmaceuticals is changing in favor of pharmacodiagnostics, and describes market models that are likely to emerge as the pharmaceutical ... |
| DNA Sequencing and PCR markets |
|
| Published : 2004/11 |
| The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. ... |
| Membrane Technology for Biopharmaceuticals |
|
| Published : 2004/11 |
| This BCC technical market report provides an in-depth analysis of the market for membrane technology across a range of life science/biotech applications including gene and protein analysis. ... |
| Therapeutics from Transgenic Sources |
|
| Published : 2004/06 |
| This important BCC report provides insight into new technologies for producing drugs, biologics, cells, tissues and organs from transgenic animals and for producing biopharmaceuticals from transgenic plants. ... |
| Markets in Geriatric Medicine Volume III: Cardiovascular Disease |
|
| Published : 2004/03 |
| The report will look at the demographics of the aging United States population, the expected incidence and prevalence of cardiovascular disease of different types, and the United States markets for these therapeutics, currently estimated at over $6.1 bill ... |
| Lead Optimization A Reinvention of the Process |
|
| Published : 2003/11 |
| This report examines in detail how to successfully integrate intelligent lead optimization library design and synthesis, advanced screening technologies, and early involvement of in vivo testing. ... |
| Drug Discovery Industry Review |
|
| Published : 2003/07 |
| Drug discovery technology involves innumerable assays to determine the molecular affinities and potential toxic effects of drug candidates. In the past decade, through the application of combinatorial chemistry and genomics, the number of drug candidates ... |
|
|